Westlake Stock Earnings Reports

Westlake reported Q3 2025 EBITDA of $313 million on $2.8 billion sales but recorded $744 million of identified items (including a $727 million noncash goodwill impairment in North American chlorovinyls and $17 million of closure-related accruals). Management excluded these identified items when discussing underlying results. The Housing & Infrastructure Products (HIP) segment remains resilient, delivering $215 million of EBITDA and benefiting from broad customer relationships, product breadth and inorganic growth (notably the planned ACI acquisition expected to close in Q1 2026). The Performance & Essential Materials (PEM) segment continues to face a prolonged global trough—particularly in PVC resin pricing—but management outlined a three-pillar turnaround (improve plant reliability, reduce costs, optimize manufacturing footprint) and targets $150–$175 million of 2025 structural savings plus an incremental $200 million of structural savings in 2026. Balance sheet: $2.1 billion cash/investments, $4.7 billion total debt; 2025 capex expected ~ $900 million. FY2025 HIP guidance narrowed to $4.2–$4.4 billion revenue and 20–22% EBITDA margin, with expectation to be toward the lower end due to softer housing demand and one-time period costs.